Test Code KS Potassium, Serum
Necessary Information
Patient's age and sex are required.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged, and the serum aliquoted into a plastic vial within 2 hours of collection.
Useful For
Evaluation of electrolyte balance, cardiac arrhythmia, muscular weakness, hepatic encephalopathy, and renal failure
Method Name
Potentiometric, Indirect Ion-Selective Electrode
Reporting Name
Potassium, SSpecimen Type
SerumSpecimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated | 48 hours |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Clinical Information
Potassium is the major cation of the intracellular fluid. Disturbance of potassium homeostasis has serious consequences. Decreases in extracellular potassium are characterized by muscle weakness, irritability, and eventual paralysis. Cardiac effects include tachycardia, other cardiac conduction abnormalities that are apparent by electrocardiographic examination, and eventual cardiac arrest.
Hypokalemia (low potassium) is common in vomiting, diarrhea, alcoholism, and folic acid deficiency. Additionally, more than 90% of hypertensive patients with aldosteronism have hypokalemia.
Abnormally high extracellular potassium levels produce symptoms of mental confusion; weakness, numbness, and tingling of the extremities; weakness of the respiratory muscles; flaccid paralysis of the extremities; slowed heart rate; and eventually peripheral vascular collapse and cardiac arrest. Hyperkalemia may be seen in end-stage renal failure, hemolysis, trauma, Addison disease, metabolic acidosis, acute starvation, dehydration, and with rapid potassium infusion.
Potassium should be monitored during treatment of many conditions but especially in diabetic ketoacidosis and any intravenous therapy for fluid replacement.
Reference Values
<1 year: not established
≥1 year: 3.6-5.2 mmol/L
Interpretation
Potassium levels below 3.0 mmol/L are associated with marked neuromuscular symptoms and are evidence of a critical degree of intracellular depletion. Potassium levels below 2.5 mmol/L are potentially life-threatening.
High potassium can be an acute medical emergency, particularly if the potassium increases over a short period of time. At values above 6.0 mmol/L, symptoms are typically apparent. Potassium levels above 6.0 mmol/L are potentially lifethreatening. Levels above 10.0 mmol/L are, in most cases, fatal.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysSpecimen Retention Time
1 weekPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
84132
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
KS | Potassium, S | 2823-3 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
KS | Potassium, S | 2823-3 |
Forms
If not ordering electronically, complete, print, and send a Renal Diagnostics Test Request (T830) with the specimen.